Medtech business hired to help produce Covid-19 test

Abingdon Health, which develops and makes rapid medical tests, has won a contract with a European customer to produce lateral flow device (LFD) components for an antigen test to detect Covid-19.

The contract is for an initial period of 12 months with an option to extend.

The initial phase of the deal is worth a minimum of £2.7m – based on minimum specified monthly order quantities –  for the first year.

All raw materials required for production will be provided by the customer. There will be a technical transfer process, paid for by the customer, which is expected to take about two months.

Chris Yates, CEO of York-based Abingdon, said: We are pleased to have signed this contract with our European partner.

“The contract highlights the strengths of Abingdon’s flexibility in being able to offer a range of first-class contract services across primary and secondary production.

“We continue to make commercial progress in other areas and look forward to updating the market in due course.”

Join us at the 2022 Rainmaker Awards